Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
| TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deal Details | 10 | 15 |
| Venture Financing | 10 | 1 |
| Tetralogic Pharma Raises US$5 Million In Venture Financing | 10 | 2 |
| TetraLogic Pharma Secures US$6 Million In Series C-1 Financing | 12 | 1 |
| TetraLogic Pharma Secures US$23 Million In Second Tranche Of Series C Financing | 13 | 2 |
| TetraLogic Pharma Raises US$2 Million In Venture Financing | 15 | 1 |
| Licensing Agreements | 16 | 1 |
| TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research | 16 | 2 |
| Equity Offering | 18 | 1 |
| TetraLogic Pharma Terminates Public Offering of Shares for USD25 Million | 18 | 2 |
| TetraLogic Pharma Completes Underwriters Exercise Of Over-Allotment Option For IPO For US$57.5 Million | 20 | 2 |
| Debt Offering | 22 | 1 |
| TetraLogic Pharma Raises USD47 Million in Private Placement of 8% Notes Due 2019 | 22 | 2 |
| Acquisition | 24 | 1 |
| TetraLogic Pharma To Acquire Shape Pharma, Biotech Company | 24 | 1 |
| TetraLogic Pharmaceuticals - Key Competitors | 25 | 1 |
| Key Employees | 26 | 1 |
| Locations And Subsidiaries | 27 | 1 |
| Head Office | 27 | 1 |
| Appendix | 28 | 1 |
| Methodology | 28 | 1 |
| About GlobalData | 28 | 1 |
| Contact Us | 28 | 1 |
| Disclaimer | 28 | 1 |